1. Asioli, S., Righi, A., de Biase, D., et al. (2011). Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas. Modern Pathology, 24, 1451–1461.
2. Bichakjian, C. K., Olencki, T., Aasi, S. Z., et al. (2018). Merkel cell carcinoma, Version1.2018, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 16, 742–774.
3. Busam, K. J., Walsh, N., & Woods, B. A. (2018). Merkel cell carcinoma. In D. E. Elder, D. Massi, R. A. Scolyer, & R. Willemze (Eds.), World Health Organization classification of skin tumors (pp. 48–50). Lyon: IARC Press.
4. Goh, G., Walradt, T., Markarov, V., et al. (2016). Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget, 7(3), 3403–3415.
5. Howlader, N., Noone, A. M., Krapcho, M., et al. (Eds.). (2016). SEER cancer statistics review, 1975–2013, National Cancer Institute. Bethesda: National Cancer Institute.